. MDS coordinate 2 vs. MDS coordinate 1 for the processed reads of 20 MS patients (red dots) and 20 healthy controls (blue dots). One outlier control sample (HC1, top-left corner) was excluded from further analysis. MDS = multidimensional scaling, MS -MS patients, HC = healthy controls.
Supplementary
. Boxplots of identified surrogate variables against sequencing run 1 (8 samples) and sequencing run 2 (32 samples) for surrogate variables 1-7 (A-G). The boxes delimit 25% and 75% of the values; the horizontal bars represent the median value. The whiskers represent values that do not exceed a distance of 1.5 times the interquartile range from the middle 50% of the data. An independent samples t-test was used to test for significant differences between run 1 and run 2. We applied a Bonferroni correction for 7 comparisons made in this test. No significant differences were observed. Figure S3 . Boxplots of identified surrogate variables against sequencing lane on the sequencer for surrogate variables 1-7 (A-G). The boxes delimit 25% and 75% of the values; the horizontal bars represent the median value. The whiskers represent values that do not exceed a distance of 1.5 times the interquartile range from the middle 50% of the data. Each surrogate variable was tested for significance against the sequencing lanes using a one-way ANOVA test. We applied a Bonferroni correction for 7 comparisons made in this test. No significant differences were observed. However, surrogate variable 2 appears to capture a technical bias in the sequencing lanes 1-4 vs. lanes 5-8. A Students' t-test assuming equal variance of the surrogate variable 2 values from lanes 1-4 against lanes 5-8 is significant (p-value 0.006). Figure S4 . Boxplots of identified surrogate variables against smoking status for surrogate variables 1-7 (A-G). Non-sm.: Non-smoker. The boxes delimit 25% and 75% of the values; the horizontal bars represent the median value. The whiskers represent values that do not exceed a distance of 1.5 times the interquartile range from the middle 50% of the data. An independent samples t-test was used to test for significant differences between smokers and non-smokers. We applied a Bonferroni correction for 7 comparisons made in this test. No significant differences were observed. Figure S5 . Boxplots of identified surrogate variables against the EDSS score (MS patients only) for surrogate variables 1-7 (A-E). Since the EDSS is not a linear scale of disability we tested for significant differences of the surrogate variable values of patients with an EDSS below the median and patients with an EDSS above the median. Patients with the median value (EDSS 2) were omitted in this test. Students t-test was used to test for significance. We applied a Bonferroni correction for 7 comparisons made in this test. No significant differences were observed. Figure S6 . Boxplots of identified surrogate variables against the disease status for surrogate variables 1-7 (A-G). The boxes delimit 25% and 75% of the values; the horizontal bars represent the median value. The whiskers represent values that do not exceed a distance of 1.5 times the interquartile range from the middle 50% of the data. An independent samples t-test was used to test for significant differences between MS patients and healthy controls. In line with the design of the surrogate variable analysis(16), no significant differences were observed between MS patients and controls for any of the surrogate variables.

Supplementary Figure S7. Boxplots of genes previously implicated in MS genomic studies by Rhead et al.(18) and Parnell et al.(9)
The boxes delimit 25% and 75% of the values; the horizontal bars represent the median value. The whiskers represent values that do not exceed a distance of 1.5 times the interquartile range from the middle 50% of the data. A) The NINJ2 gene which showed higher levels of DNA methylation in CD4+ T cells in the study by Rhead et al.(18) was not significantly differentially expressed between healthy controls (HC) and MS patient (MS) in the present study. B) The SLFN12 gene which showed higher levels of DNA methylation in CD4+ T cells in the study by Rhead et al.(18) was not significantly differentially expressed between healthy controls (HC) and MS patient (MS) in the present study. C) The EOMES gene which showed lower levels of gene expression in whole blood of MS patients in a study by Parnell et al.(9) was not significantly differentially expressed between healthy controls (HC) and MS patient (MS) in the present study. D) The TBX21 gene which showed lower levels of gene expression in whole blood of MS patients in a study by Parnell et al.(9) was not significantly differentially expressed between healthy controls (HC) and MS patient (MS) in the present study.
Supplementary methods
Power analysis
The Benjamini-Hochberg False Discovery Rate is applied in DeSeq2(14). An assumption we make is that there are 100 genes significant in the hypothetical differential expression analysis, one of those 100 (r) is our gene of interest with the observations from the study we performed. For m tests with a nominal alpha of 0.05 () the FDR is calculated: The p-values of m tests are ranked lowest to highest (p1 ≤ p2 ≤ p3 … ≤ pm). We then find the highest rank r such that pr ≤ r/m*. The terms 1 through r are considered significant. Our analysis included 12,624 genes (m) so we can calculate pr by /(m/r): 0.05/(12,624/100) = 4*10 -4 . This value is the threshold nominal p-value to make it to a FDR corrected significant pvalue in this hypothetical dataset of unknown sample size (this unknown will be calculated using the metrics from our dataset).
In order to set the sample-size range we have taken three genes from our observations; the gene with the overall strongest p-value, the strongest gene which was previously implicated; EOMES from Parnell et al.(9) and the weakest gene which was previously implicated; SLFN12 from Rhead et al.(18) 
